Propafenone Overdose Lawsuits

Watson Pharmaceuticals issued a Propafenone HCL recall on March 23, 2009, for one lot of 225mg tablets that could contain more of the active drug than they were supposed to. This could lead to a Propafenone overdose, potentially causing serious side effects.

PROPAFENONE RECALL LAWSUIT STATUS: The potential for Propafenone recall lawsuits are being reviewed by lawyers on behalf of individuals who required medical care as a result of problems that may have been caused by receiving too much of the generic heart drug, including low-blood pressure or arrhythmias.

>>REVIEW A PROPAFENONE LAWSUIT WITH A LAWYER<<

MANUFACTURER: Watson Phamaceuticals, Inc.

OVERVIEW: On March 23, 2009, a Propafenone recall was issued by generic drug maker Watson Pharmaceuticals, Inc., as some tablets sold in 100 count bottles could be oversized.

The recall applies to one lot of Propafenone HCL 225mg tablets, with lot number 112680A and an expiration date of July 31, 2010.

The recall only applies to this one lot and does not apply to other doses, tablets made by other generic drug makers or the brand name versions of the drug, which are distributed as Rythmol, Rytmonorm and Propafenonum.

PROPAFENONE OVERDOSE: Propafenone HCL (hydrochloride) is a very dose specific medication that has narrow therapeutic index, underlining the importance of patients receiving the proper amount of the drug prescribed by their doctor.

Some patients could be sensitive to even small variations in the dose contained in a tablet, and receiving too much of the mediation could cause serious side effects of propafenone overdose, such as low blood pressure or irregular heart beat.

Symptoms of a low blood pressure or arrhythmia (irregular heartbeat) could include:

• Chest Pain, Palpitations or Pounding in the Chest
• Fainting, Dizzy Feeling or Light Headedness
• Weakness
• Fatigue
• Shortness of Breath